Precision medicine in hemato-oncology – treatment of refractory multiple myeloma with massive extramedullary involvement using BRAF/MEK inhibitors
Klinicka onkologie · 2025
DOI: 10.48095/ccko2025390 ↗Kurz gefasst
Fallbericht in der Zeitschrift Klinicka onkologie, 2025. Verfasst von M Štork und 21 weiteren Autor:innen. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins B-raf, Multiple Myeloma, Precision Medicine, Protein Kinase Inhibitors.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Zitieren
APA
Štork, M., Kotašková, J., Ondroušková, E., Borský, M., Marečková, A., Sendlerová, N., Mayerová, J., Brada, M., Boichuk, I., Menšíková, K., Adam, Z., Krejčí, M., Sandecká, V., Jelínková, Z., Krtička, M., Nekuda, V., Bilčíková, M., Hrabčáková, V., Vojtková, L., …, & Pour, L. (2025). Precision medicine in hemato-oncology – treatment of refractory multiple myeloma with massive extramedullary involvement using BRAF/MEK inhibitors. Klinicka onkologie. https://doi.org/10.48095/ccko2025390
Vancouver
Štork M, Kotašková J, Ondroušková E, Borský M, Marečková A, Sendlerová N, et al. Precision medicine in hemato-oncology – treatment of refractory multiple myeloma with massive extramedullary involvement using BRAF/MEK inhibitors. Klinicka onkologie. 2025. doi:10.48095/ccko2025390
BibTeX
@article{tork2025,
author = {Štork, M and Kotašková, J and Ondroušková, E and Borský, M and Marečková, A and Sendlerová, N and Mayerová, J and Brada, M and Boichuk, I and Menšíková, K and Adam, Z and Krejčí, M and Sandecká, V and Jelínková, Z and Krtička, M and Nekuda, V and Bilčíková, M and Hrabčáková, V and Vojtková, L and Jarošová, M and Šlampa, P and Pour, L},
title = {Precision medicine in hemato-oncology – treatment of refractory multiple myeloma with massive extramedullary involvement using BRAF/MEK inhibitors},
journal = {Klinicka onkologie},
year = {2025},
doi = {10.48095/ccko2025390}
}
EUVIMED